Autonomic Nervous System Monitoring: Failed Clinical Utility

Author: Joe Colomobo

The Importance of Parasympathetic Monitoring

As the title may suggest the use of ANS monitoring may not lead to accurate clinical diagnoses and treatment for many ailments using other technologies available to healthcare professionals. What is missing from this title is the fact that without measuring the Parasympathetic nervous system in total and independently, a correct diagnosis would not be provided. This problem exists in the industry through HRV (Heart Rate Variability) btb-readings, such as btb-Blood Pressure, Pulse Wave Velocity, and more.

The ANS has two main independent components: 
Parasympathetic Nervous System
Sympathetic Nervous System

Collectively, these branches are known as the P&S nervous systems.  Therefore, there must be at least two separate and independent variables to measure true ANS activity.  The result of this single composite variable is that all btb-measures of cardiac activity force assumption and approximation to theorize underlying Parasympathetic or Sympathetic activity. 

Clinically this is important, especially in light of the fact that most diseases, disorders, therapies and treatments affect (directly or indirectly) only one of the ANS branches.  When the two arms are examined as a single parameter, neither one is accurately represented.

This is not theory. 

It is fundamental math (algebra) and the solution to this problem was proven by a group of MIT & Harvard researchers and is owned and patented by Physio PS. 

Physio PS is the only company (patented, proven, peer reviewed) that can effectively monitor both branches of the Autonomic Nervous System.

As this information becomes more widely known there are many implications to the medical community. Subsequently, as the medical community, CMS and insurance companies, and more and more patients become aware of this shortfall in current practice, more focus will be placed in seeking the technology provided by Physio PS. 

Indeed, it is the only technology that can fill this void and present more accurate data for diagnosis and treatment of many ailments.

Currently, a vast majority of patients that are suffering from P&S dysfunction(s) are being told by their physicians that it is all in their heads.  Their physicians say this because they cannot measure anything abnormal in these patients with any other technology.  It has been Dr. Colombo’s recent clinical experience that without advertisement in any form, but simply by patient word of mouth, the literal handful of autonomic clinics nation-wide are seeing 8 to 10 or more new patients per day! 

As we begin to release this information to the community and is more frequently peer reviewed by medical professionals, Physio PS believes this will accelerate opportunities to provide more comprehensive and accurate care to estimated 70 million patients with dysautonomia.


Physio PS © 2020 All Rights Reserved. The material and information provided by Physio PS is for general information purposes only. You should not rely upon this material or information for basis of making healthcare, treatment or diagnosis decisions. While Physio PS strives to provide the most correct and up to date information and data, Physio PS makes no representations or warranties of any kind, expressed or implied about the completeness, accuracy, reliability, suitability or availability with respect to the information, products, services or related graphics contained.  Any reliance placed on such material is therefore strictly at your own risk. Reporting Information is supplied under license by NCRC LLC.
* ‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.